Aquestive Therapeutics

Patent cliffs & loss of exclusivity

Contract Manufacturing & Development, Drug Delivery Technology

Company

CAGE Code5MZL2
Legal NameAquestive Therapeutics, Inc.
Company Operating StatusActive
Contact Page URLhttps://aquestive.com/#contact-aquestive
Crunchbase URLhttps://www.crunchbase.com/organization/monosolrx
Full Address30 Technology Drive, Warren, New Jersey 07059, US
LinkedIn URLhttps://www.linkedin.com/company/aquestive
Pitchbook URLhttps://pitchbook.com/profiles/company/10508-50

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. ZUPLENZONDANSETRONSmall mol.Jul 2030
  2. ZUPLENZONDANSETRONSmall mol.Jul 2030
  3. EXSERVANRILUZOLESmall mol.

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Aquestive Therapeutics — patent cliffs & loss of exclusivity | CliffBio